How Bluesky is coping with influx of liberals rushing to quit XNASA’s SWIM Submersible Droid Prototypesjili 10 。

Posts Strong Adjusted EBITDA Margin ‎ 1 ‎ for Fiscal Year 2024 and Returns to Positive Sequential Growth in Fiscal Q4 2024 CINCINNATI, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (" Quipt ” or the " Company ”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fourth quarter and fiscal year 2024 financial results and operational highlights. These results pertain to the three months and year ended September 30, 2024 and are reported in U.S. Dollars. The Company no longer qualifies as a "foreign private issuer” as such term is defined in Rule 405 under the U.S. Securities Act of 1933, as amended, and Rule 3b-4 under the Securities Exchange Act of 1934, as amended (the "Exchange Act”), which means that the Company, as of October 1, 2024, has been required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act applicable to U.S. domestic issuers. Accordingly, the Company is now required to prepare its financial statements filed with the Securities and Exchange Commission (" SEC ”) in accordance with generally accepted accounting principles in the United States (" U.S. GAAP ”), starting with the Company's fourth quarter and full year fiscal 2024 results. In addition, as required pursuant to section 4.3(4) of National Instrument 51-102 - Continuous Disclosure Obligations , the Company must restate and file under the Company's profile on SEDAR+ (www.sedarplus.com), ‎its interim financial reports for the fiscal year ended September 30, 2024 in accordance with U.S. GAAP, such interim financial reports having previously been prepared in accordance with the International Financial Reporting Standards (" IFRS ”). Conference Call Quipt will host its Earnings Conference Call on Tuesday, December 17, 2024 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing: Following the conclusion of the call, a replay of the webcast will be available on the Company's website for at least the first year following the event. Financial Highlights : "Our results for fiscal 2024 reflect the resilience of our business and the scalability of our operating model,” said Gregory Crawford, Chairman and CEO of Quipt. "Despite facing unique challenges this year, we delivered record revenue, positive year-over-year organic growth and maintained a strong Adjusted EBITDA Margin 1 . This performance underscores the strength of our diversified product offering, go-to-market strategy and the adaptability of our team. As we look ahead to calendar 2025 and beyond, we have a high confidence level in our ability to return to consistent, historical organic growth levels. Our focus remains on leveraging the demographic trends such as the aging population and increasing prevalence of chronic respiratory conditions, while expanding our referral base through our growing salesforce and strategic investments. By combining these initiatives with our disciplined approach to inorganic growth, we aim to strengthen our market position and deliver sustained growth. The demand for in-home respiratory solutions continues to grow, and our ability to provide comprehensive, patient-centric care positions us well to capture this opportunity. We remain committed to operational excellence, enhancing our recurring revenue base, and executing on our growth roadmap to drive both scale and profitability. With a strong balance sheet, we are well-equipped to allocate capital toward strategic opportunities, while also investing in organic growth to build long-term shareholder value.” "Our financial performance in fiscal 2024 highlights the stability of our core operations,” added Hardik Mehta, Chief Financial Officer of Quipt. "In the fourth quarter, we returned to positive sequential organic revenue growth, which demonstrates the regained momentum in our business. As we move into calendar 2025, we are seeing strengthening trends across our major product categories, supported by solid referral activity and steady demand for our end-to-end respiratory care solutions. These factors give us confidence that we will return to consistent, historical organic growth levels in calendar 2025. With a scalable operating model, a focused growth strategy, and favorable demographic tailwinds, we are well-positioned to seize the opportunities in front of us.” ABOUT QUIPT HOME MEDICAL CORP. The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company's organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient's services, and making life easier for the patient. Forward-Looking Statements Certain statements contained in this press release constitute "forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 or "forward-looking information" as such term is ‎‎‎‎‎‎defined in applicable Canadian securities legislation (collectively, "forward-looking statements”). The words "may", "would", "could", "should", "potential", ‎‎‎‎‎‎‎"will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect", "outlook", or the negatives thereof or variations of such words, and similar expressions ‎‎‎‎‎as ‎they relate to the Company, including: the Company anticipating a return to historical organic growth levels; are intended to ‎identify forward-looking information. All statements ‎other ‎than ‎statements of ‎‎historical fact, including those that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-‎looking statements and may involve estimates, assumptions and uncertainties that could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. Such statements reflect the ‎Company's ‎current ‎views and ‎‎intentions with respect to future ‎events, and current information available to the ‎Company, and ‎are ‎subject to ‎‎certain risks, uncertainties and ‎assumptions, including, without limitation: the ‎Company successfully identifying, ‎‎‎negotiating and ‎completing additional acquisitions; operating and other financial metrics maintaining their ‎‎current trajectories, the Company not being impacted by any further external and unique events like the Medicare ‎‎75/25 rate cut and the Change Healthcare cybersecurity incident for the remainder of the calendar year and in 2025; and the ‎Company not being subject to a material change to it cost structure. Many ‎factors could cause the actual ‎results, ‎‎performance or achievements that may be ‎expressed ‎or implied by such ‎forward-looking statements to ‎vary from ‎‎those described herein should one or more ‎of these ‎risks or ‎uncertainties materialize. Examples of such ‎risk ‎factors ‎include, without limitation: risks related ‎to credit, market ‎‎‎(including equity, commodity, foreign exchange ‎and interest ‎rate), ‎liquidity, operational ‎‎(including technology ‎and ‎infrastructure), reputational, insurance, ‎strategic, ‎regulatory, legal, ‎environmental, and ‎capital adequacy; the ‎‎general business and economic conditions in ‎the regions ‎in which the ‎Company operates; ‎the ability of the ‎‎Company to execute on key priorities, including the ‎successful ‎completion of ‎acquisitions, ‎business retention, and ‎‎strategic plans and to attract, develop and retain ‎key ‎executives; difficulty ‎integrating ‎newly acquired businesses; ‎‎the ability to implement business strategies and ‎‎pursue business opportunities; low ‎profit ‎market segments; ‎‎disruptions in or attacks (including cyber-attacks) on ‎‎the Company's information ‎technology, ‎internet, network ‎‎access or other voice or data communications systems or ‎‎services; the evolution of ‎various types ‎of fraud or other ‎‎criminal behavior to which the Company is exposed; the ‎‎failure of third parties to ‎comply with ‎their obligations to ‎‎the Company or its affiliates; the impact of new and ‎‎changes to, or application of, ‎current ‎laws and regulations; ‎‎decline of reimbursement rates; dependence on few ‎‎payors; possible new drug ‎discoveries; a ‎novel business ‎model; ‎dependence on key suppliers; granting of permits ‎‎and licenses in a highly ‎regulated ‎business; legal proceedings and litigation, including as it relates to the civil ‎‎investigative demand ("CID”) ‎received from the Department of Justice; ‎increased competition; ‎changes in ‎foreign currency rates; ‎increased ‎‎funding costs and market volatility due to ‎market illiquidity and ‎competition for ‎funding; the ‎availability of funds ‎‎and resources to pursue operations; ‎critical accounting ‎estimates and changes ‎to accounting ‎standards, policies, ‎‎and methods used by the Company; the Company's status as an emerging growth company and a smaller reporting company; the occurrence of ‎natural and unnatural ‎catastrophic ‎events or health epidemics or concerns; as well as those risk factors ‎discussed or ‎‎referred to ‎in the Company's disclosure ‎documents filed with ‎United States Securities and Exchange ‎Commission ‎‎(the "SEC”) and ‎available at www.sec.gov, including the Company's most recent Annual Report on Form 10-K, and with ‎the securities ‎regulatory authorities in certain provinces of ‎Canada and ‎‎‎available at www.sedarplus.com. Should any ‎factor affect ‎the Company in an unexpected manner, or ‎should ‎‎‎assumptions underlying the forward-looking ‎statement prove ‎incorrect, the actual results or events may ‎differ ‎‎‎materially from the results or events predicted. ‎Any such forward-‎looking statements are expressly qualified ‎in their ‎‎‎entirety by this cautionary statement. Moreover, ‎the Company ‎does not assume responsibility for the ‎accuracy or ‎‎‎completeness of such forward-looking ‎statements. The ‎forward-looking statements included in this ‎press release ‎‎‎is made as of the date of this press ‎release and the ‎Company undertakes no obligation to publicly ‎update or revise ‎‎‎any forward-looking statements, ‎other than as ‎required by applicable law‎.‎ Non-GAAP Financial Measures This press release refers to "Organic Growth”, "Recurring Revenue”, "Adjusted EBITDA”, "Adjusted EBITDA Margin” and "Adjusted Net Debt to Adjusted EBITDA Leverage Ratio”, which are non-GAAP financial measures that do not have standardized meanings prescribed by U.S. GAAP. The ‎Company's presentation of these financial measures may not be comparable to similarly titled measures used by ‎other companies. These financial measures are intended to provide additional information to investors concerning ‎the Company's performance.‎ Organic Growth is calculated as the increase in revenues of $34.2 million, less the revenues contributed by acquisitions of $27.1 million, divided by fiscal year 2023 revenue of $211.7 million, or 3%. Recurring Revenue for fiscal 2024 is calculated as rentals of medical equipment of $94.3 million plus sales of respiratory resupplies of $96.5 million for a total of $190.8 million, divided by total revenues of $245.9 million, or 78%. Adjusted EBITDA is calculated as net loss, and adding back depreciation and amortization, right-of-use operating lease amortization and interest, interest expense, net, provision (benefit) for income taxes, professional fees related to civil investigative demand and loss of foreign private issuer status, stock-based compensation, acquisition-related costs, loss on extinguishment of debt, gain (loss) on foreign currency transactions, change in fair value of derivative liability - interest rate swap, and share of loss of equity method investment. The following table shows our non-GAAP measure, Adjusted EBITDA, reconciled to our net income (loss) for the ‎following indicated periods‎ (in $millions)‎:‎ Net Debt to Adjusted EBITDA Leverage Ratio is calculated as Net Debt, divided by (Adjusted EBITDA for Q4 times four), and is reconciled as follows (in $millions): Cole Stevens VP of Corporate Development Quipt Home Medical Corp. 859-300-6455 [email protected] Gregory Crawford Chief Executive Officer Quipt Home Medical Corp. 859-300-6455 [email protected] ___________________________________ 1 Non-GAAP financial measure or ratio. See "Non-GAAP Financial Measures”.‎

Pro Picks is a weekly column where AP Pro Football Writer Rob Maaddi shares his picks for upcoming games. For all previous Pro Picks, head here . Playoff berths, draft positioning and more are up for grabs in Week 17. There’s going to be plenty of football on television this holiday week with the NFL playing games on five out of six days, starting with a doubleheader on Christmas Day featuring four of the AFC’s top five teams. Patrick Mahomes and the two-time defending Super Bowl champion Kansas City Chiefs visit Russell Wilson and the Pittsburgh Steelers on Wednesday. Then, two-time NFL MVP Lamar Jackson and the Baltimore Ravens take on C.J. Stroud and the Houston Texans. The Bears host the Seahawks on Thursday night and there are three games on Saturday, making Sunday’s schedule light at nine games. The Lions-49ers wrap up the weekend on Monday night. Pro Picks goes for another winning week. Line: Chargers minus 4 The Chargers would clinch a wild-card spot with a victory over the Patriots, who battled hard against the Bills. Los Angeles is 9-2 against the spread as favorites. Justin Herbert is 9-0 ATS in the Eastern time zone in his career. The Patriots have lost eight straight home games in December. BEST BET: CHARGERS: 23-16 Line: Bengals minus 3 Joe Burrow and the Bengals have to win to keep their slim playoff hopes alive. They’re favorites for the 12th time this season despite a losing record. The Broncos would clinch a wild-card berth with a win. They’re 11-4 ATS. UPSET SPECIAL: BRONCOS: 23-22 Line: Chiefs minus 3 The Chiefs can set a franchise record for wins in the regular season and wrap up the No. 1 seed along with home-field advantage throughout the AFC playoffs as they continue their quest for a third straight Super Bowl title. Kansas City got another playmaker when wide receiver Marquise Brown made his season debut. Mahomes is 3-0 with 14 touchdowns and no interceptions in his career vs. Pittsburgh. The scuffling Steelers are trying to snap a two-game losing streak after missing an opportunity to clinch the AFC North. Wide receiver George Pickens should return from a hamstring injury and he’ll open up the passing game for Wilson and the offense. CHIEFS: 24-20 Line: Ravens minus 5 1/2 The Ravens have won five in a row over the Texans, including 34-10 in a divisional playoff game last season. Baltimore can move into first place in the AFC North with a win and loss by Pittsburgh. But Jackson and Derrick Henry face a tough challenge against Houston’s defense. Stroud and the Texans are reeling after losing receiver Tank Dell to a devastating knee injury. RAVENS: 23-19 Line: Seahawks minus 3 1/2 The Seahawks have to win to maintain slim playoff hopes. The Bears have lost nine straight. Geno Smith and Jaxon Smith-Njigba should have a big day against Chicago’s pass defense. SEAHAWKS: 26-20 Line: Rams minus 6 A four-game winning streak has the Rams on the verge of securing the NFC West. Los Angeles aims to avenge a lopsided loss to Arizona in Week 2. The Cardinals were eliminated from the playoffs and are reduced to playing spoiler. With Kyren Williams leading the rushing attack, the Rams don’t have to rely on Matthew Stafford’s passing as much. RAMS: 26-16 Line: Bills minus 10 The Bills will know going in if they have a shot at the AFC’s No. 1 seed. If the Chiefs beat the Steelers and lock it up, Buffalo’s main priority will be keeping Josh Allen and everyone healthy. Still, they can rest in Week 18. After a subpar effort against the Patriots, the Bills can’t take Aaron Rodgers and the Jets lightly. BILLS: 27-16 Line: Raiders minus 1 The Raiders already hurt their draft positioning by beating the Jaguars last week. Another win could further knock them down and negatively impact their quest for a franchise quarterback. But coach Antonio Pierce wants to win and the players don’t care about draft slots. The Saints can’t get to the end of the season fast enough. RAIDERS: 20-16 Line: Buccaneers minus 8 The Panthers have embraced the spoiler role and coach Dave Canales will try to derail his former team’s playoff hopes. Bryce Young keeps improving and Chuba Hubbard is having a career year. The Buccaneers would’ve lost to Carolina last month if Hubbard didn’t fumble in overtime. Baker Mayfield and a turnover-prone offense have to overcome a depleted defense that couldn’t stop Cooper Rush and the Cowboys. BUCCANEERS: 26-20 Line: Jaguars minus 1 The winner of this one really loses because it’ll be costly in the race for draft positioning. TITANS: 19-17 Line: Colts minus 8 The Giants have come too far to lose the No. 1 pick in the draft. The Colts are clinging to slim playoff hopes. Jonathan Taylor and Anthony Richardson combined for 308 yards and four TDs against the Titans. They could have similar results against New York. COLTS: 27-16 Line: Eagles minus 9 1/2 The Cowboys are left to play for a winning record after being eliminated from the playoff race. The Eagles still need a win to secure the NFC East, but are almost locked into the No. 2 seed. If Jalen Hurts can’t play because of a concussion, Dallas has a shot against Kenny Pickett. Saquon Barkley is 268 yards away from breaking Eric Dickerson’s single-season rushing record. He could have a big day facing the fifth-worst run defense in the NFL. EAGLES: 24-17 Line: Vikings minus 1 The Vikings are two wins away from the NFC’s No. 1 seed with Sam Darnold. Let that sink in. But those won’t be easy victories. Minnesota has to beat Green Bay and then Detroit on the road to win the NFC North and get home-field advantage throughout the playoffs. The Vikings defeated the Packers 31-29 in Green Bay in September. They’re getting the Packers on short rest off a Monday night rout. The Vikings have been overlooked and underrated. This is a statement game. VIKINGS: 27-22 Line: Dolphins minus 6 1/2 Tua Tagovailoa and the Dolphins still have slim playoff changes and get an opportunity to win a game in cold weather. A loss helps the Browns hold onto a top-five pick in the draft. DOLPHINS: 25-16 Line: Commanders minus 4 The Falcons regained control of their NFC South hopes when the Buccaneers lost. Now, they have a tough test against the Commanders with Michael Penix Jr. making his second start facing off against Jayden Daniels in another matchup between rookie QBs. Daniels beat Caleb Williams and the Bears earlier this season on a Hail Mary. Washington clinches a playoff berth with a win or a loss by Tampa Bay. COMMANDERS: 24-23 Line: Lions minus 4 The Lions aim to avenge their loss in the NFC championship game, though this matchup lost its luster because the 49ers are eliminated from the playoff race. Detroit clinches the NFC’s No. 1 seed with a win if the Packers beat the Vikings. If Minnesota beats Green Bay, the Lions have to beat the Vikings in Week 18 to win the division and secure the top seed so the result against San Francisco won’t matter. In that case, Dan Campbell could choose to rest some of his starters in preparation for a winner-take-all regular-season finale. LIONS: 26-23 Last week: 12-4. Against spread: 8-7-1 Overall: Straight up: 168-72. Against spread: 131-105-4. Prime-time: Straight up: 39-14. Against spread: 29-23-1. Best Bet: Straight up: 9-7. Against spread: 8-8. Upset Special: Straight up: 9-7. Against spread: 9-7. AP NFL: https://apnews.com/hub/nfl

Drone sightings lead

A delegation of the Andhra Pradesh government led by IT and Human Resources Development Minister Nara Lokesh and Health Minister Y. Satya Kumar visited the Tata Digital Nerve Centre (DiNC) at Kolar in Karnataka on December 16, Monday. The DiNC is the Tata Consultancy Services (TCS)’s innovative delivery model designed to connect, communicate, coordinate and deliver healthcare by leveraging people, infrastructure and a robust digital platform. During the visit, which included a walkthrough at the Vemgal PHC and Health and Wellness Centre at Shettihalli that are powered by DiNC, Mr. Lokesh emphasised the importance of adopting innovative healthcare models to improve public health systems in Andhra Pradesh. Tata MD (Medical & Diagnostics) Limited MD Girish Krishnamurthy gave a presentation on the services being rendered by DiNC and highlighted its impact on government health programmes in Karnataka. He organised live demonstrations of DiNC’s use cases in reproductive and child health, non-communicable disease management and mental health coordination. An official release from the A.P. government stated that the visit by the Ministers highlighted the government’s commitment to adopting cutting-edge technologies for the transformation of public healthcare system. The insights gained by them would aid in developing advanced, tech-enabled healthcare initiatives in Andhra Pradesh, thereby ensuring improved healthcare access and outcomes for its citizens. Andhra Pradesh Economic Development Board CEO C.M. Saikanth Varma and other officials accompanied the Ministers. Published - December 17, 2024 03:42 am IST Copy link Email Facebook Twitter Telegram LinkedIn WhatsApp RedditAfter his team's 102-89 home win on Wednesday night over Purdue Fort Wayne, Penn State coach Mike Rhoades challenged his team's fan base to show up and make more noise. "Sweat with us," he said at one point. At 5-0, the Nittany Lions haven't had to sweat much to get off to a fast start. They might not have to expend much perspiration to make it 6-0 on Monday when they meet Fordham in a semifinal matchup at the Sunshine Slam tournament in Daytona Beach, Fla. Penn State hasn't played a strong schedule so far, but the team has been impressive. It's averaging 98.2 points per game and 13.8 steals per game, both of which ranked second in Division I through Saturday's play. The Nittany Lions were seventh per kenpom.com in turnover rate, forcing 25.3 per 100 possessions. Point guard Ace Baldwin Jr. is leading the charge, scoring 16.4 points and dishing out 7.8 assists while chipping in 2.6 steals. Zach Hicks has nearly doubled his scoring average from 8.4 last season to 15.8 this season, while Northern Illinois transfer Yanic Konan Niederhauser has beefed up the interior, tallying 12.2 points and 7.2 rebounds. Meanwhile, Fordham (3-3) is coming off a 73-71 home loss Friday night against Drexel in New York. The Rams blew a seven-point lead early in the second half and missed a chance to force overtime when leading scorer Jackie Johnson III missed a layup as time expired. Johnson, a UNLV transfer, is averaging 19 points per game and is making nearly 48 percent of his shots as one of three Rams with double-figure scoring averages. Jahmere Tripp scores at an 11.0 clip while Japhet Medor is contributed 10.5, but Fordham is struggling to make shots, canning only 41.5 percent from the field. The Rams were picked for a 14th-place finish in the Atlantic 10 despite returning more scoring than any team in the league except for VCU. Third-year coach Keith Urgo thinks his team can defy low external expectations. "We're experienced and I think we're poised to have a tremendous year," he said. --Field Level Media

IR movie review of 'Wicked': Somewhere over the rainbow, witches are greenJPMorgan Chase & Co. Boosts Doximity (NASDAQ:DOCS) Price Target to $48.00

Stratos Wealth Advisors LLC lifted its position in shares of NVIDIA Co. ( NASDAQ:NVDA – Free Report ) by 1.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 343,398 shares of the computer hardware maker’s stock after purchasing an additional 3,330 shares during the period. NVIDIA accounts for about 1.9% of Stratos Wealth Advisors LLC’s holdings, making the stock its 4th biggest position. Stratos Wealth Advisors LLC’s holdings in NVIDIA were worth $41,702,000 at the end of the most recent reporting period. Several other hedge funds and other institutional investors have also added to or reduced their stakes in NVDA. Stratos Wealth Partners LTD. lifted its holdings in NVIDIA by 1.9% during the third quarter. Stratos Wealth Partners LTD. now owns 1,159,770 shares of the computer hardware maker’s stock worth $140,843,000 after acquiring an additional 21,685 shares during the period. Pachira Investments Inc. increased its position in shares of NVIDIA by 21.5% during the 3rd quarter. Pachira Investments Inc. now owns 6,166 shares of the computer hardware maker’s stock valued at $749,000 after purchasing an additional 1,093 shares during the last quarter. Richard W. Paul & Associates LLC raised its stake in shares of NVIDIA by 0.8% during the 3rd quarter. Richard W. Paul & Associates LLC now owns 21,210 shares of the computer hardware maker’s stock worth $2,576,000 after purchasing an additional 160 shares during the period. Strategic Advocates LLC boosted its holdings in shares of NVIDIA by 10.0% in the 3rd quarter. Strategic Advocates LLC now owns 103,313 shares of the computer hardware maker’s stock worth $12,546,000 after buying an additional 9,402 shares during the last quarter. Finally, Inspire Advisors LLC grew its position in NVIDIA by 10.5% during the third quarter. Inspire Advisors LLC now owns 13,866 shares of the computer hardware maker’s stock valued at $1,684,000 after buying an additional 1,314 shares during the period. 65.27% of the stock is currently owned by hedge funds and other institutional investors. Insider Activity In related news, insider Donald F. Robertson, Jr. sold 4,500 shares of the stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $116.51, for a total transaction of $524,295.00. Following the completion of the sale, the insider now directly owns 492,409 shares in the company, valued at $57,370,572.59. This represents a 0.91 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link . Also, Director Tench Coxe sold 1,000,000 shares of NVIDIA stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $119.27, for a total value of $119,270,000.00. Following the completion of the transaction, the director now directly owns 5,852,480 shares in the company, valued at $698,025,289.60. This trade represents a 14.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here . In the last 90 days, insiders sold 2,156,270 shares of company stock valued at $254,784,327. Corporate insiders own 4.23% of the company’s stock. Wall Street Analysts Forecast Growth Get Our Latest Research Report on NVIDIA NVIDIA Stock Down 3.2 % NVDA opened at $141.95 on Friday. The business’s fifty day simple moving average is $134.01 and its 200 day simple moving average is $122.28. NVIDIA Co. has a 52 week low of $45.01 and a 52 week high of $152.89. The company has a quick ratio of 3.79, a current ratio of 4.10 and a debt-to-equity ratio of 0.13. The stock has a market cap of $3.48 trillion, a PE ratio of 55.89, a P/E/G ratio of 1.53 and a beta of 1.66. NVIDIA ( NASDAQ:NVDA – Get Free Report ) last posted its quarterly earnings data on Wednesday, November 20th. The computer hardware maker reported $0.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.12. The firm had revenue of $35.08 billion during the quarter, compared to analysts’ expectations of $33.15 billion. NVIDIA had a return on equity of 114.83% and a net margin of 55.69%. The company’s revenue for the quarter was up 93.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.38 EPS. As a group, research analysts expect that NVIDIA Co. will post 2.68 earnings per share for the current fiscal year. NVIDIA announced that its Board of Directors has initiated a share repurchase program on Wednesday, August 28th that permits the company to repurchase $50.00 billion in outstanding shares. This repurchase authorization permits the computer hardware maker to buy up to 1.6% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s leadership believes its shares are undervalued. NVIDIA Dividend Announcement The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Thursday, December 5th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Thursday, December 5th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.03%. NVIDIA’s payout ratio is 1.57%. NVIDIA Profile ( Free Report ) NVIDIA Corporation provides graphics and compute and networking solutions in the United States, Taiwan, China, Hong Kong, and internationally. The Graphics segment offers GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, and solutions for gaming platforms; Quadro/NVIDIA RTX GPUs for enterprise workstation graphics; virtual GPU or vGPU software for cloud-based visual and virtual computing; automotive platforms for infotainment systems; and Omniverse software for building and operating metaverse and 3D internet applications. Read More Five stocks we like better than NVIDIA 3 Fintech Stocks With Good 2021 Prospects Vertiv’s Cool Tech Makes Its Stock Red-Hot There Are Different Types of Stock To Invest In MarketBeat Week in Review – 11/18 – 11/22 Why Are These Companies Considered Blue Chips? 2 Finance Stocks With Competitive Advantages You Can’t Ignore Receive News & Ratings for NVIDIA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NVIDIA and related companies with MarketBeat.com's FREE daily email newsletter .

In response to fraud-related losses in the hundreds of millions, Hamburg-based copper producer Aurubis is undergoing significant leadership changes. On Monday evening, the company confirmed that three out of four executive board members , including CEO Roland Harings , will step down. This move follows “advanced talks” with the supervisory board about terminating their positions. Harings, along with CFO Rainer Verhoeven and Chief Production Officer Heiko Arnold , will leave the executive board by February, June, and September of next year, respectively. Despite the impending departures, Aurubis stated that these executives will continue fulfilling their duties until their exit dates. The supervisory board initiated an investigation into the leadership’s role in connection with multiple cases of fraud and theft that caused significant financial damage. These incidents included a €169 million shortfall in metal stock discovered during regular checks, resulting in manipulated samples and over-invoicing. As a result, the company reported a 33% drop in earnings before interest and taxes (EBT) to €349 million for the fiscal year 2022-23, with revenue falling nearly 8% to €17.1 billion. Despite these challenges, Harings emphasized that security measures have since been strengthened to prevent future incidents. A final decision on the leadership changes is expected to be made by the supervisory board on Tuesday.

Jennison Associates LLC Makes New $1.69 Million Investment in SBA Communications Co. (NASDAQ:SBAC)Sleep Sprays Market Insights: In-Depth Analysis of Key Players and Market Dynamics

NFL on Netflix: Christmas Day games are a 1st for streaming giant

Southeast Asia's Digital Revolution Kicks Off at DigiTech ASEAN & AI Connect 2024 in BangkokOppenheimer & Co. Inc. trimmed its stake in shares of Skyworks Solutions, Inc. ( NASDAQ:SWKS – Free Report ) by 32.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,375 shares of the semiconductor manufacturer’s stock after selling 1,141 shares during the period. Oppenheimer & Co. Inc.’s holdings in Skyworks Solutions were worth $235,000 at the end of the most recent reporting period. Several other hedge funds have also modified their holdings of SWKS. Innealta Capital LLC bought a new stake in Skyworks Solutions during the 2nd quarter worth about $27,000. Rothschild Investment LLC acquired a new stake in shares of Skyworks Solutions during the 2nd quarter worth approximately $27,000. Blue Trust Inc. grew its position in shares of Skyworks Solutions by 79.7% during the 2nd quarter. Blue Trust Inc. now owns 336 shares of the semiconductor manufacturer’s stock worth $36,000 after buying an additional 149 shares during the period. Matrix Trust Co bought a new stake in shares of Skyworks Solutions during the third quarter worth approximately $39,000. Finally, Catalyst Capital Advisors LLC acquired a new position in Skyworks Solutions in the third quarter valued at approximately $49,000. 85.43% of the stock is owned by institutional investors. Analyst Upgrades and Downgrades Several brokerages have commented on SWKS. Susquehanna dropped their target price on shares of Skyworks Solutions from $110.00 to $100.00 and set a “neutral” rating for the company in a research report on Wednesday, November 13th. Morgan Stanley dropped their price objective on Skyworks Solutions from $117.00 to $87.00 and set an “equal weight” rating for the company in a report on Wednesday, November 13th. JPMorgan Chase & Co. reduced their target price on Skyworks Solutions from $120.00 to $100.00 and set a “neutral” rating on the stock in a report on Wednesday, November 13th. B. Riley lowered their price target on Skyworks Solutions from $120.00 to $110.00 and set a “buy” rating for the company in a research note on Thursday, November 14th. Finally, Craig Hallum decreased their price objective on shares of Skyworks Solutions from $140.00 to $105.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Three research analysts have rated the stock with a sell rating, fifteen have given a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $101.00. Insider Buying and Selling In related news, SVP Carlos S. Bori sold 10,177 shares of the business’s stock in a transaction that occurred on Monday, October 14th. The stock was sold at an average price of $97.63, for a total transaction of $993,580.51. Following the transaction, the senior vice president now directly owns 27,026 shares of the company’s stock, valued at approximately $2,638,548.38. The trade was a 27.36 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website . Also, SVP Robert John Terry sold 10,522 shares of the firm’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $88.01, for a total value of $926,041.22. Following the sale, the senior vice president now directly owns 15,960 shares of the company’s stock, valued at $1,404,639.60. This represents a 39.73 % decrease in their position. The disclosure for this sale can be found here . Over the last three months, insiders have sold 31,841 shares of company stock worth $3,034,265. Insiders own 0.34% of the company’s stock. Skyworks Solutions Trading Up 0.4 % Skyworks Solutions stock opened at $85.41 on Friday. The company has a market cap of $13.66 billion, a price-to-earnings ratio of 23.08, a P/E/G ratio of 1.84 and a beta of 1.21. The firm has a 50-day moving average of $93.49 and a 200-day moving average of $99.86. The company has a debt-to-equity ratio of 0.16, a current ratio of 5.54 and a quick ratio of 2.19. Skyworks Solutions, Inc. has a one year low of $82.13 and a one year high of $120.86. Skyworks Solutions ( NASDAQ:SWKS – Get Free Report ) last issued its quarterly earnings results on Tuesday, November 12th. The semiconductor manufacturer reported $1.55 EPS for the quarter, beating the consensus estimate of $1.52 by $0.03. The firm had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Skyworks Solutions had a return on equity of 13.71% and a net margin of 14.27%. The business’s quarterly revenue was down 15.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.95 earnings per share. On average, equities analysts expect that Skyworks Solutions, Inc. will post 4.45 earnings per share for the current fiscal year. Skyworks Solutions Dividend Announcement The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 24th. Investors of record on Tuesday, December 3rd will be paid a $0.70 dividend. The ex-dividend date of this dividend is Tuesday, December 3rd. This represents a $2.80 annualized dividend and a dividend yield of 3.28%. Skyworks Solutions’s dividend payout ratio is presently 75.68%. About Skyworks Solutions ( Free Report ) Skyworks Solutions, Inc, together with its subsidiaries, designs, develops, manufactures, and markets proprietary semiconductor products in the United States, China, South Korea, Taiwan, Europe, the Middle East, Africa, and the rest of Asia-Pacific. Its product portfolio includes amplifiers, antenna tuners, attenuators, automotive tuners and digital radios, DC/DC converters, demodulators, detectors, diodes, wireless analog system on chip products, directional couplers, diversity receive modules, filters, front-end modules, hybrids, light emitting diode drivers, low noise amplifiers, mixers, modulators, optocouplers/optoisolators, phase locked loops, phase shifters, power dividers/combiners, power over ethernet, power isolators, receivers, switches, synthesizers, timing devices, voltage controlled oscillators/synthesizers, and voltage regulators. Featured Articles Want to see what other hedge funds are holding SWKS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Skyworks Solutions, Inc. ( NASDAQ:SWKS – Free Report ). Receive News & Ratings for Skyworks Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skyworks Solutions and related companies with MarketBeat.com's FREE daily email newsletter .TCU's TD barrage breaks open tight game vs. Arizona